- News & Analysis
Page 803
Grifols pumps $50m into Alkahest
The pharmaceutical company has acquired a 45% stake in Alkahest, which aims to fight diseases using plasma transplants from younger patients.
Mar 5, 2015Macrolide launches from Harvard with $22m
Harvard life sciences spin-out Macrolide secures $22m at launch.
Mar 5, 2015ChipCare finds $5m in its blood
Toronto medtech spin-out ChipCare secures $5m in series A round.
Mar 5, 2015RainDance to summon up $60m IPO
The genomics tool producer has raised more than $100m from investors including General Electric and Myriad Genetics.
Mar 3, 2015Chiasma closes $70m series E
The Ofer-backed acromegaly treatment developer raised an initial $33.8m in January, following a cancelled deal with pharmaceutical company Roche.
Mar 2, 2015Chiasma closes $70m series E
The Ofer-backed acromegaly treatment developer raised an initial $33.8m in January, following a cancelled deal with pharmaceutical company Roche.
Mar 2, 2015About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
© 2026 Mawsonia Ltd. All rights reserved.test regLogin